TOPIC:

Biogen Idec

Watch breaking news videos and read news updates about Biogen Idec on FOXBusiness.com.

LATEST VIDEOS

Big Banks, Fake Earnings

10/14/2009|Web Exclusive

Big Banks, Fake EarningsWe break down if Wall Street's biggest titans are actually on the road to recovery.

LATEST STORIES

Tuesday Stories: Buffett’s Rail Bet; Break Up The Banks?; Overweight AND Depressed « The Brian

The Brian Sullivan Blog

big banks? Housing nightmare: Paid $559,000, now worth $360,000 China rushing toward a Japan-like bubble Barrons: Biogen 's a buy GMAC's lifeline is economy's noose 5 myths about the land of opportunity Berry: Don't worry about the weaker

Blog|11/03/2009

Market Winners & Losers: Amazon, MEMC Electronic Materials

By David O'Brien| FOXBusiness| Markets

drop in quarterly profit and a flat forecast. Broadcom shares ended Friday at $28.50, down $2.23 on the day. Biogen Idec Inc . (BIIB) The biotech company saw its stock fall 7.2% following sector trends. BIIB shares last traded at $43

Story|10/23/2009

Biogen, Elan Lead Drug Stocks Lower

By Val Brickates Kennedy| MarketWatch Pulse| Markets

Brickates Kennedy MarketWatch Pulse BOSTON -- Partners Biogen Idec and Elan Corp. led drug stocks lower early Friday as ..... the NYSE Arca Biotechnology Index fell 1% to 889.92. Biogen shares were off 5% at $44.80, while Elan shares tumbled

Story|10/23/2009

Biogen Idec Net Up 34%, Revenue Up 2.5%

By Robert Daniel| MarketWatch Pulse| Markets

Robert Daniel MarketWatch Pulse TEL AVIV -- Biogen Idec Inc ., the Cambridge, Mass., biotechnology giant, reported ..... 580 million. And revenue included $284 million from Biogen Idec 's joint venture with Genentech related to Rituxan

Story|10/20/2009

Stocks In Focus For Tuesday

By MarketWatch| MarketWatch| Markets

expected to report third-quarter earnings of 47 cents a share, according to analysts surveyed by Thomson Reuters. Biogen Idec Inc . (BIIB) is forecast to post earnings of $1.04 a share in the third quarter, according to analysts surveyed

Story|10/19/2009

Stocks In Focus For Monday

By MarketWatch| MarketWatch| Markets

After Friday's closing bell, Biogen Idec Inc . (BIIB) said it will extend its ..... shares by about three months. Biogen said it will offer $14.50 a share ..... million shares outstanding, and Biogen said it has tendered about 28

Story|10/16/2009

Biogen Extends Hostile Takeover Offer By 3 Months

By Wallace Witkowski| MarketWatch Pulse| Markets

MarketWatch Pulse SAN FRANCISCO -- Biogen Idec Inc . said late Friday it will extend ..... shares by about three months. Biogen said it will offer $14.50 a share ..... million shares outstanding, and Biogen said it has tendered about 28

Story|10/16/2009

Week Ahead: Earnings and Windows 7

By Dunstan Prial| FOXBusiness| Markets

eBay (EBAY), on Wednesday; and Amazon.com (AMZN), on Thursday. Biotechs will also get attention next week. Biogen Idec (BIIB) reports on Tuesday. Also reporting are Gilead Sciences (GILD) on Tuesday; Genzyme (GENZ) and Amgen

Story|10/16/2009

Johnson & Johnson Renegotiates Deal with Elan

By Kathryn Elizabeth Tuggle| FOXBusiness| Markets

ruled earlier in September that the deal between the two giants breached a partnership struck between Elan and Biogen Idec (BIIB). Biogen and Elan jointly own and sell the drug Tysabri, which treats multiple sclerosis. As a result, J&J has

Story|09/14/2009

Biogen Reiterates Hostile Bid For Facet Biotech

By Wallace Witkowski| MarketWatch Pulse| Markets

Wallace Witkowski MarketWatch Pulse SAN FRANCISCO -- Biogen Idec Inc . late Tuesday reiterated its $14.50 a share, or ..... Facet's rejection of the offer earlier in the day. Biogen said it was disappointed that Facet rejected the offer

Story|09/08/2009

«123»